Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) compared with fluticasone propionate/salmeterol combination (FP/SAL) in adults and adolescents with persistent asthma
Abstract
Introduction: null The combination of FF, a novel inhaled corticosteroid and VI, a long-acting beta 2 null agonist, is under development as a once-daily treatment for asthma and COPD. null null Objectives: null To compare the efficacy of FF/VI with FP/SAL in patients with persistent asthma. null null Methods: null In a randomised, double-blind, double-dummy, parallel-group study, 806 patients received FF/VI (100/25mcg, n=403) or FP/SAL...
Paper Details
Title
Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) compared with fluticasone propionate/salmeterol combination (FP/SAL) in adults and adolescents with persistent asthma
Published Date
Sep 1, 2012
Journal
Volume
40
Pages
1795
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History